Dr. Sidharth  Mehan

Dr. Sidharth Mehan

Researcher
Bapex Pharma and Nutraceuticals Pvt. Ltd, India


Highest Degree
Ph.D. in Pharmacology from Techno Global University, India

Share this Profile

Biography

Dr. Sidharth Mehan is currently working as Associate Professor at Rajendra Institute of Technology & Sciences, Sirsa, Haryana, India. He obtained his PhD in Pharmacology from TGU, Shilong, Meghalya, India, and M. Pharm. in Pharmacology from ISF (Indo-Soviet-Friendship) College of Pharmacy, Ferozepur Road, Ghal Kalan, India. In past he worked as trainee at SWISS Pharma, RIICO, Ganganagar, Rajasthan, India, Assistant Professor in Pharmacology Department at G.D. Memorial College of Pharmacy, Jodhpur, Rajasthan, India, and Assistant Manager in Research & Development at BAPEX Pharma and Nutraceuticals Pvt. Ltd., Ajmer, Rajasthan. His area of research interest related to Molecular Mechanisms involved in Neurodegenerative Processes, Animal Behavioral Activities and Identify the Strategies to improve Neuronal Communication with special emphasis on Dementia of Alzheimer type, Huntington disease, Neuropathic pain, Cardiac and Renal Toxicities, and to Identify, Explore and Scientifically Proof the new Herbal Medicines and Phyto-chemicals Compounds and its Derivatives for the Better Human use. He was received Best student award in B.Pharm Batch, and Three Times Scholarship as well as college topper in B.Pharm Batch Punjab Technical University, Jalandhar, Punjab. He is member of advisory board in many national and international journals. He is also serving as reviewer in of Renal Failure, London, UK, Neural Regeneration Research, China. He also attended several conferences in India and other countries and performed many presentations. He has published 48 articles in journals contributed as author/co-author. He also supervised 9 B.Pharm students, 17 M.Pharm and 1 M.S Pharm, and 1 PhD student as supervisor/co-supervisor.

Area of Interest:

Pharmacology and Toxicology
100%
Neuropharmacology
62%
Phytochemicals
90%
Herbal Formulation
75%
Pharmacology
55%

Education

2013

Ph.D.

Techno Global University, India

Pharmacology

2009

M. Pharm.

ISF College of Pharmacy, India

Pharmacology

2007

B. Pharm.

Baba Isher Singh (BIS) Institute of Sciences and Technology, Gagra Village, Punjab, India

Pharmacy

Selected Publications

  1. Kaur, G., U. Kukkar and S. Mehan, 2016. Ameliorative strategies of natural adenyl cyclase activator to restore the mitochondrial dysfunction against 6-ohda induced Parkinson's type neurodegenerative disorders. IJPPR, 6: 21-30.

  2. Parveen, S., S. Mehan, G. Kaur and U. Kukkar, 2015. Therapeutic potential of nature molecule forskolin mediated cyclic AMP/CREB activation for the amelioration of neurodegenerative disorder like huntington's. Int. J. Rec. Adv. Pharm. Res., 5: 296-301.

  3. Kaur, R., S. Parveen, S. Mehan, D. Khanna and S. Kalra, 2015. Neuroprotective effect of ellagic acid against chronically scopolamine induced Alzheimer’s type memory and cognitive dysfunctions: Possible behavioural and biochemical evidences. Int. J. Preven. Med. Res, 1: 45-64.

  4. Kaur, R., S. Mehan, S. Parveen, D. Khanna and S. Kalra, 2015. Precautionary ellagic acid treatment ameliorates chronically administered scopolamine induced alzheimer's type memory and cognitive dysfunctions in rats. Pharmacologia, 6: 192-212.

  5. Kaur, R., S. Mehan, D. Khanna and S. Kalra, 2015. Polyphenol ellagic acid-targeting to brain: A hidden treasure. Int. J. Neurol. Res., 1: 141-152.
    Direct Link  |  

  6. Kaur, R., S. Mehan, D. Khanna and S. Kalra, 2015. Ameliorative treatment with ellagic acid in scopolamine induced alzheimer's type memory and cognitive dysfunctions in rats. Austin J. Clin. Neurol., 2: 1-11.

  7. Kaur, G., S. Mehan and D. Khanna, 2015. Pharmacotherapeutic strategies associated with blood brain barrier to prevent brain tumors. Int. J. Recent Adv. Pharm. Edu Res., 5: 51-86.

  8. Bala, R., D. Khanna, S. Mehan and S. Kalra, 2015. Experimental evidence for the potential of Lycopene in the management of scopolamine induced amnesia. RSC Adv., 5: 72881-72892.
    CrossRef  |  Direct Link  |  

  9. Thakur, T., S. Mehan, R. Kaur and S. Kalra, 2014. Huntington's disease: A hard nut to break. Int. J. Recent Adv. Pharm. Res., 4: 38-58.

  10. Paliwal, Y.K., S. Mehan, K.R.V. Bijjem and P.L. Sharma, 2014. Renoprotective effect of ace Inhibitor -lisinopril and heme Oxygenase-1 Inducer-hemin combination against streptozotocin induced advanced diabetic nephropathy in rats. Pharmacologia, 5: 60-75.
    CrossRef  |  Direct Link  |  

  11. Gagandeep, B.S., Y. Sharma, R. Ahlawat, S. Rani and S. Mehan, 2014. Evaluate adaptogenic activity of fruits of Lagenaria siceraria by animal models. Int. J. Recent. Adv. Pharm. Res., 4: 85-101.
    Direct Link  |  

  12. Sharma, R., S. Mehan, S. Kalra and D. Khanna, 2013. Tephrosia purpurea-A magical herb with blessings in human biological system. Int. J. Recent. Adv. Pharm. Res., 3: 12-22.
    Direct Link  |  

  13. Paliwal, Y.K., S. Mehan and P.L. Sharma, 2013. Heme oxygenase-1: A magic stick for diabetes and renal disorders. Int. J. Recent Adv. Pharm. Res., 4: 9-22.
    Direct Link  |  

  14. Heer, H. and S. Mehan, 2013. Cellular signals like MAPK/NF-κB/m-TOR mediated drug resistance: A promising concept in cancer research. Pharmacologia, 4: 414-427.

  15. Beniwal, L., D. Khanna and S. Mehan, 2013. Spices, Fruits, Nuts and vitamins: Preventive interventions for myocardial infarction. Pharmacologia, 4: 553-570.

  16. Bansal, N., S. Mehan, S. Kalra and D. Khanna, 2013. Boswellia serrata-frankincense (A Jesus Gifted Herb): An updated pharmacological profile. Pharmacologia, 4: 457-463.

  17. Vyas, T., S. Mehan, V. Sehgal, V. Dave and A. Prajapat et al., 2011. Alzheimer's-A neurodegenerative disease: Start to end. Int. J. Pharm. Prof. Res., 2: 422-434.

  18. Tiwari, M., S. Mehan, M.P. Singh, H. Meena, K. Jangid and A. Deora, 2011. Neuroinflammatory mechanisms of cytokines in multiple sclerosis. Int. J. Pharm. Prof. Res., 2: 359-372.

  19. Sharma, G., S. Kumar, N. Sharma and S. Mehan, 2011. An updated review on multiple sclerosis. Asian J. Biopharm. Pharm. Res., 3: 415-428.

  20. Prajapat, A., V. Dave, R. Moyra, S. Mehan, G. Lal and P. Joshi, 2011. A review on effectiveness of herbal drugs in AIDS. Int. J. Biopharma Toxicol. Res., 1: 115-136.

  21. Mehan, S., R. Arora, V. Sehgal, G. Sharma, S. Singh and S. Kawal, 2011. Effect of Salvia officinalis L. (Sage) leaves in intracerebroventricular streptozotocin (ICV-STZ) induced Alzheimer's type dementia. Int. J. Bio. Tox. Res., 1: 90-107.

  22. Mehan, S., R. Arora, D. Sharma, H. Meena, G. Sharma and T. Vyas, 2011. Dementia: A complete literature review on various mechanisms involves in pathogenesis and an intracerebroventricular streptozotocin induced Alzheimer's disease. Int. J. Pharm. Prof. Res., 2: 406-421.

  23. Mehan, S., H. Meena, D. Sharma and R. Sankhla, 2011. JNK: A stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities. J. Mol. Neurosci., 43: 376-390.
    CrossRef  |  PubMed  |  Direct Link  |  

  24. Mehan, S., G. Sharma, S. Kumar, M. George and L. Joseph et al., 2011. Evaluation of the antipyretic and analgesic activity of aqueous & chloroform extract of Phyllostachys bambusoides leaves. Int. J. Pharm. Prof. Res., 2: 355-358.

  25. Mehan, S., A. Verma, K.L. Bedi, V. Sehgal, A. Gupta, H. Meena and D. Sharma, 2011. Effect of mitogen activated protein kinase inhibitor in animal model of Alzheimer's disease. Int. J. Pharm. Prof. Res., 1: 212-223.

  26. Gupta, A., V. Sehgal and S. Mehan, 2011. Hyperlipidemia: An updated review. Int. J. Biopharm. Toxicol. Res., 1: 81-89.

  27. Verma, L., M. Sakir, N. Singh, R.M. Gilhotra and S. Mehan, 2010. Development of phase change solutions for ophthalmic drug delivery based on ion activated and pH induced polymers. Int. J. Pharm. Prof. Res., 1: 137-144.
    Direct Link  |  

  28. Nain, V.S., S. Nain, S. Mehan, J. Panu, R.R.D. Budhiraja, 2010. Apocynin supplementation: Comparison of thermal perception and oxidative stress in diabetic induced neuropathy. Int. J. Pharm. Prof. Res., 1: 114-121.
    Direct Link  |  

  29. Mehan, S., V.S. Nain, H. Meena, D. Sharma, R. Sankhla and M. Singh, 2010. Comparative effect of phosphodiesterase inhibitors on intracerebroventricular colchicine model of memory impairments in rats. Int. J. Pharm. Prof. Res., 1: 122-136.
    Direct Link  |  

  30. Mehan, S., D. Mishra, R. Sankhla and M. Singh, 2010. p38 MAPK kinase at the crossroads of Alzheimer`s disease. Int. J. Pharm. Prof. Res., 1: 52-60.

  31. Deshmukh, R., V. Sharma, S. Mehan, N. Sharma and K.L. Bedi, 2009. Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine: A PDE1 inhibitor. Eur. J. Pharmacol., 620: 49-56.
    PubMed  |  Direct Link  |